Fundly.ai, which is a fintech startup focused on Pharma has recently raised $3Mn in its seed funding. This round was led by Accel, India. Apart from that, several angel investors participated in this round along with Multiply Ventures.
The funds would be used to increase strong engagement with current customers and expand into new geographies. The rest of the funds would be used in building technology and offering new products.
Fundly.ai was established in 2021, by Shreeram Ramanathan as well as Amit Chawla to offer allied solutions and innovative financing to specialty players, distribution tails, major brands, etc. This is to work closely along with pharma-based industries.
Chawla made an announcement on LinkedIn regarding the investment and said, “With this new funding, we are excited to expand our reach and explore untapped markets, bringing our vision of a more efficient and effective pharma supply chain to an even larger demographic.”
In addition to that, Chawla also said that the startup has already crossed $1Mn in April 2022. The mission of Fundly.ai is to further provide a one-shop stop with a collaboration of MSME financing and supply chain to optimize distribution operations.